Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-24-006947

Head of Development sold 262 shares at $221.23 ($57,962)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Singhal Priya Head of Development 2024-02-22 Sale 10b5-1 −262 $221.23 $57,962 4,886.09 D: show line 1 in the form
Open-market sales · 262 sh · avg $221.23 · $57,962
Loading xslF345X05/form4.xml…